Latest Schedule 13G passive stakes

CIBC Private Wealth Group LLC reports a 5.7% stake in Accel Entertainment, Inc. Class A Common stock, indicating a shift in beneficial ownership.

American Century entities and Stowers Institute report a combined 0.1% ownership stake in Proficient Auto Logistics, Inc.

American Century Investment Management, Inc., along with its affiliates, has reported a beneficial ownership stake of 4.4% in Plexus Corp.

EdgePoint Investment Group Inc. has disclosed a beneficial ownership of 4.21% of Twist Bioscience Corp.'s common stock as of June 30, 2026.

American Century Investment Management, Inc., along with its parent companies, has reported beneficial ownership of 3.8% of IBEX Limited's common stock.

EdgePoint Investment Group Inc. has disclosed beneficial ownership of 17,171,552 shares, representing 4.95% of Restaurant Brands International Inc.'s common stock, as of June 30, 2026.

American Century Investment Management, Inc., along with its parent entities, has filed a Schedule 13G for Embecta Corp., reporting a minimal beneficial ownership of common stock.

EdgePoint Investment Group Inc. has disclosed a beneficial ownership of 5.13% in RB Global, Inc., holding 9,562,646 common shares as of June 30, 2026.

American Century Investment Management, Inc. and its affiliates have increased their beneficial ownership of CECO Environmental Corp. common stock to 3.6%.

EdgePoint Investment Group Inc. has disclosed an increased beneficial ownership of Mattel, Inc. common stock, now holding 17.57% of the class.

American Century Investment Management, Inc. has disclosed an increased beneficial ownership of Astronics Corporation's common stock, now holding 4.5% of the class.

American Century Investment Management, Inc. and its affiliates report a beneficial ownership of 8.3% of WestAmerica Bancorporation's common stock as of June 30, 2026.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 9.9% of Traws Pharma, Inc. common stock.

American Century Investment Management, Inc., along with its affiliates, has reported an increased beneficial ownership of The Bancorp, Inc.'s common stock, now holding 8.6% of the class.

Deep Track Capital, LP, along with affiliated entities, has disclosed a beneficial ownership of 7.45% of Nurix Therapeutics, Inc. common stock as of June 30, 2026.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 4.9% of Tonix Pharmaceuticals Holding Corp. common stock, including shares issuable upon warrant exercise.

American Century entities and Stowers Institute report updated beneficial ownership of Spectrum Brands Holdings common stock.

Sirenia Capital Management LP and Alex Silverstein have reported a 0% beneficial ownership of Q32 Bio Inc. common stock, indicating a full divestment.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 6.1% of InflaRx N.V.'s ordinary shares.

Deep Track Capital, along with affiliated entities, has reported beneficial ownership of 8.33% of X4 Pharmaceuticals' common stock as of June 30, 2026.

American Century Capital Portfolios, Inc., American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively increased their beneficial ownership of OneWater Marine Inc. Class A Common Stock to 7.0% and 13.0% respectively.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 4.3% of Immunome Inc.'s common stock as of June 30, 2026.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 7.2% of First Tracks Biotherapeutics, Inc. common stock.

Several American Century entities have amended their Schedule 13G filing, reporting changes in their beneficial ownership of Kohl's Corporation common stock.

Sirenia Capital Management LP and Alex Silverstein have reported beneficial ownership of 3.1% of Dianthus Therapeutics, Inc. common stock, including shares issuable from options.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 3,592,740 shares, representing 3.25% of Viridian Therapeutics, Inc.'s common stock.

Sirenia Capital Management LP and Alex Silverstein have jointly filed a Schedule 13G, reporting beneficial ownership of 9.5% of Design Therapeutics, Inc. common stock.

Several American Century entities and the Stowers Institute for Medical Research have updated their beneficial ownership filings for Infinity Natural Resources, Inc., reporting significant stakes.

Investment firm Deep Track Capital, through its associated entities, has reported beneficial ownership of 4,000,000 shares, representing 3.82% of Personalis, Inc.'s common stock.

Sirenia Capital Management LP and Alex Silverstein have reported a beneficial ownership of 4.8% in Cybin Inc. common shares, including shares issuable upon warrant exercise.